{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:57:35Z","timestamp":1789963055422,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,8,28]],"date-time":"2003-08-28T00:00:00Z","timestamp":1062028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,8,28]],"date-time":"2003-08-28T00:00:00Z","timestamp":1062028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2003,9,1]]},"DOI":"10.1038\/sj.cgt.7700617","type":"journal-article","created":{"date-parts":[[2003,8,28]],"date-time":"2003-08-28T11:37:47Z","timestamp":1062070667000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-\u03b2 gene and poly I: poly C in a murine lung metastasis model"],"prefix":"10.1038","volume":"10","author":[{"given":"Fuminori","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyoshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Hashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,8,28]]},"reference":[{"key":"BF7700617_CR1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1189\/jlb.71.4.565","volume":"71","author":"DL Brassard","year":"2002","unstructured":"Brassard DL, Grace MJ, Bordens RW . Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol. 2002;71:565\u2013581.","journal-title":"J Leukoc Biol"},{"key":"BF7700617_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1359-6101(01)00035-1","volume":"13","author":"I Gresser","year":"2002","unstructured":"Gresser I, Belardelli F . Endogenous type I interferons as a defense against tumors. Cytokine Growth Factor Rev. 2002;13:111\u2013118.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF7700617_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","volume":"13","author":"H Ikeda","year":"2002","unstructured":"Ikeda H, Old LJ, Schreiber RD . The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002;13:95\u2013109.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF7700617_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1089\/10430349950017978","volume":"10","author":"J Nemunaitis","year":"1999","unstructured":"Nemunaitis J, Fong T, Burrows F, et al. Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma. Hum Gene Ther. 1999;10:1289\u20131298.","journal-title":"Hum Gene Ther"},{"key":"BF7700617_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/sj.cgt.7700019","volume":"6","author":"J Nemunaitis","year":"1999","unstructured":"Nemunaitis J, Fong T, Robbins JM, et al. Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma. Cancer Gene Ther. 1999;6:322\u2013330.","journal-title":"Cancer Gene Ther"},{"key":"BF7700617_CR6","doi-asserted-by":"publisher","first-page":"9456","DOI":"10.1073\/pnas.86.23.9456","volume":"86","author":"Y Watanabe","year":"1989","unstructured":"Watanabe Y, Kuribayashi K, Miyatake S, et al. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA. 1989;86:9456\u20139460.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700617_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/sj.cgt.7700224","volume":"7","author":"S Fujii","year":"2000","unstructured":"Fujii S, Huang S, Fong TC, et al. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients. Cancer Gene Ther. 2000;7:1220\u20131230.","journal-title":"Cancer Gene Ther"},{"key":"BF7700617_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.cgt.7700333","volume":"8","author":"G Cao","year":"2001","unstructured":"Cao G, Su J, Lu W, et al. Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cancer Gene Ther. 2001;8:497\u2013505.","journal-title":"Cancer Gene Ther"},{"key":"BF7700617_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/10799900260100222","volume":"22","author":"JL Brown","year":"2002","unstructured":"Brown JL, Barsoum J, Qin XQ . CD4+ T helper cell-independent antitumor response mediated by murine IFN-beta gene delivery in immunocompetent mice. J Interferon Cytokine Res. 2002;22:719\u2013728.","journal-title":"J Interferon Cytokine Res"},{"key":"BF7700617_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/sj.cgt.7700364","volume":"8","author":"CM Iqbal Ahmed","year":"2001","unstructured":"Iqbal Ahmed CM, Johnson DE, Demers GW, et al. Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers. Cancer Gene Ther. 2001;8:788\u2013795.","journal-title":"Cancer Gene Ther"},{"key":"BF7700617_CR11","first-page":"1258","volume":"8","author":"JI Izawa","year":"2002","unstructured":"Izawa JI, Sweeney P, Perrotte P, et al. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Clin Cancer Res. 2002;8:1258\u20131270.","journal-title":"Clin Cancer Res"},{"key":"BF7700617_CR12","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/sj.gt.3300990","volume":"6","author":"A Natsume","year":"1999","unstructured":"Natsume A, Mizuno M, Ryuke Y, et al. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Therapy. 1999;6:1626\u20131633.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR13","first-page":"83","volume":"108","author":"H Tada","year":"2001","unstructured":"Tada H, Maron DJ, Choi EA et al. Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. J Clin Invest. 2001;108:83\u201395.","journal-title":"J Clin Invest"},{"key":"BF7700617_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.gt.3300792","volume":"6","author":"T Nomura","year":"1999","unstructured":"Nomura T, Yasuda K, Yamada T, et al. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Therapy. 1999; 6:121\u2013129.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR15","first-page":"292","volume":"5","author":"J Nemunaitis","year":"1998","unstructured":"Nemunaitis J, Bohart C, Fong T, et al. Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. Cancer Gene Ther. 1998;5:292\u2013300.","journal-title":"Cancer Gene Ther"},{"key":"BF7700617_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nbt0797-647","volume":"15","author":"NS Templeton","year":"1997","unstructured":"Templeton NS, Lasic DD, Frederik PM, et al. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol. 1997;15:647\u2013652.","journal-title":"Nat Biotechnol"},{"key":"BF7700617_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nbt0297-167","volume":"15","author":"Y Liu","year":"1997","unstructured":"Liu Y, Mounkes LC, Liggitt HD, et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol. 1997;15:167\u2013173.","journal-title":"Nat Biotechnol"},{"key":"BF7700617_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.gt.3300482","volume":"4","author":"S Li","year":"1997","unstructured":"Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Therapy. 1997;4:891\u2013900.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.gt.3301460","volume":"8","author":"F Sakurai","year":"2001","unstructured":"Sakurai F, Nishioka T, Saito H, et al. Interaction between DNA\u2013cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Therapy. 2001;8:677\u2013686.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/71429","volume":"6","author":"AB Al-Mehdi","year":"2000","unstructured":"Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med. 2000;6:100\u2013102.","journal-title":"Nat Med"},{"key":"BF7700617_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1172\/JCI965","volume":"101","author":"G Thurston","year":"1998","unstructured":"Thurston G, McLean JW, Rizen M, et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest. 1998;101:1401\u20131413.","journal-title":"J Clin Invest"},{"key":"BF7700617_CR22","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/sj.gt.3301784","volume":"9","author":"F Sakurai","year":"2002","unstructured":"Sakurai F, Terada T, Yasuda K, et al. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Therapy. 2002;9:1120\u20131126.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.gt.3300865","volume":"6","author":"S Li","year":"1999","unstructured":"Li S, Tseng WC, Stolz DB, et al. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Therapy. 1999;6:585\u2013594.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1023\/A:1012151616910","volume":"14","author":"K Kawabata","year":"1997","unstructured":"Kawabata K, Kondo M, Watanabe Y, et al. Non-polarized secretion of mouse interferon-beta from gene-transferred human intestinal Caco-2 cells. Pharm Res. 1997;14:483\u2013485.","journal-title":"Pharm Res"},{"key":"BF7700617_CR25","first-page":"1","volume-title":"Lymphokines and Interferons: A Practical Approach","author":"Y Watanabe","year":"1987","unstructured":"Watanabe Y, Kawade Y . Induction, production and purification of natural mouse IFN-\u03b1 and -\u03b2. In: Clemens MJ, Morris AG, Gearing AJH, eds. Lymphokines and Interferons: A Practical Approach. Oxford: IRL Press; 1987: 1\u201314."},{"key":"BF7700617_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-94-009-3543-3_28","volume-title":"The Biology of the Interferon System 1986","author":"Yoshimi Kawade","year":"1987","unstructured":"Kawade Y, Watanabe Y . Characterization of rat monoclonal antibodies to mouse interferon-\u03b1 and -\u03b2. In: Cantell K, Schellekens H, eds. The Biology of the Interferon System 1987. Dordrecht: Martinus Nijhoff; 1987: 197\u2013201."},{"key":"BF7700617_CR27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1084\/jem.159.5.1560","volume":"159","author":"GL Spitalny","year":"1984","unstructured":"Spitalny GL, Havell EA . Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med. 1984; 159: 1560\u20131565.","journal-title":"J Exp Med"},{"key":"BF7700617_CR28","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/sj.gt.3301026","volume":"6","author":"M Whitmore","year":"1999","unstructured":"Whitmore M, Li S, Huang L . LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Therapy. 1999;6:1867\u20131875.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR29","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1089\/10430349950016375","volume":"10","author":"SW Dow","year":"1999","unstructured":"Dow SW, Elmslie RE, Fradkin LG, et al. Intravenous cytokine gene delivery by lipid\u2013DNA complexes controls the growth of established lung metastases. Hum Gene Ther. 1999;10:2961\u20132972.","journal-title":"Hum Gene Ther"},{"key":"BF7700617_CR30","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4049\/jimmunol.163.3.1552","volume":"163","author":"SW Dow","year":"1999","unstructured":"Dow SW, Fradkin LG, Liggitt DH, et al. Lipid\u2013DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J Immunol. 1999;163:1552\u20131561.","journal-title":"J Immunol"},{"key":"BF7700617_CR31","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","volume":"93","author":"DM Klinman","year":"1996","unstructured":"Klinman DM, Yi AK, Beaucage SL, et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA. 1996;93:2879\u20132883.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700617_CR32","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","volume":"157","author":"ZK Ballas","year":"1996","unstructured":"Ballas ZK, Rasmussen WL, Krieg AM . Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol. 1996;157:1840\u20131845.","journal-title":"J Immunol"},{"key":"BF7700617_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1126\/science.273.5273.352","volume":"273","author":"Y Sato","year":"1996","unstructured":"Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 1996;273:352\u2013354.","journal-title":"Science"},{"key":"BF7700617_CR34","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1128\/jvi.71.12.9163-9169.1997","volume":"71","author":"S Ghazizadeh","year":"1997","unstructured":"Ghazizadeh S, Carroll JM, Taichman LB . Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy. J Virol. 1997;71:9163\u20139169.","journal-title":"J Virol"},{"key":"BF7700617_CR35","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1089\/hum.1997.8.17-2019","volume":"8","author":"L Qin","year":"1997","unstructured":"Qin L, Ding Y, Pahud DR, et al. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther. 1997;8:2019\u20132029.","journal-title":"Hum Gene Ther"},{"key":"BF7700617_CR36","doi-asserted-by":"publisher","first-page":"13338","DOI":"10.1074\/jbc.274.19.13338","volume":"274","author":"Y Liu","year":"1999","unstructured":"Liu Y, Thor A, Shtivelman E, et al. Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J Biol Chem. 1999;274:13338\u201313344.","journal-title":"J Biol Chem"},{"key":"BF7700617_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1006\/mthe.2002.0598","volume":"5","author":"NS Yew","year":"2002","unstructured":"Yew NS, Zhao H, Przybylska M, et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther. 2002;5:731\u2013738.","journal-title":"Mol Ther"},{"key":"BF7700617_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0006-291X(02)00210-3","volume":"293","author":"K Yasuda","year":"2002","unstructured":"Yasuda K, Ogawa Y, Kishimoto M, et al. Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. Biochem Biophys Res Commun. 2002;293:344\u2013348.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF7700617_CR39","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/sj.gt.3301097","volume":"7","author":"G McLachlan","year":"2000","unstructured":"McLachlan G, Stevenson BJ, Davidson DJ, et al. Bacterial DNA is implicated in the inflammatory response to delivery of DNA\/DOTAP to mouse lungs. Gene Therapy. 2000;7: 384\u2013392.","journal-title":"Gene Therapy"},{"key":"BF7700617_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/10430349950019011","volume":"10","author":"NS Yew","year":"1999","unstructured":"Yew NS, Wang KX, Przybylska M, et al. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther. 1999;10:223\u2013234.","journal-title":"Hum Gene Ther"},{"key":"BF7700617_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s002620050472","volume":"46","author":"Z Dong","year":"1998","unstructured":"Dong Z, Juang SH, Kumar R, et al. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene. Cancer Immunol Immunother. 1998;46: 137\u2013146.","journal-title":"Cancer Immunol Immunother"},{"key":"BF7700617_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.bi.51.070182.001343","volume":"51","author":"P Lengyel","year":"1982","unstructured":"Lengyel P . Biochemistry of interferons and their actions. Annu Rev Biochem. 1982;51:251\u2013282.","journal-title":"Annu Rev Biochem"},{"key":"BF7700617_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3109\/02841868909111205","volume":"28","author":"I Gresser","year":"1989","unstructured":"Gresser I . Antitumor effects of interferon. Acta Oncol. 1989;28:347\u2013353.","journal-title":"Acta Oncol"},{"key":"BF7700617_CR44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/JVI.73.2.1411-1418.1999","volume":"73","author":"J Gao","year":"1999","unstructured":"Gao J, De BP, Banerjee AK . Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway. J Virol. 1999;73:1411\u20131418.","journal-title":"J Virol"},{"key":"BF7700617_CR45","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.4049\/jimmunol.124.5.2157","volume":"124","author":"S Targan","year":"1980","unstructured":"Targan S, Dorey F . Interferon activation of \u2018pre-spontaneous killer\u2019 (pre-SK) cells and alteration in kinetics of lysis of both \u2018pre-SK\u2019 and active SK cells. J Immunol. 1980;124:2157\u20132161.","journal-title":"J Immunol"},{"key":"BF7700617_CR46","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/S0002-9440(10)65007-9","volume":"156","author":"A Albini","year":"2000","unstructured":"Albini A, Marchisone C, Del Grosso F, et al. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: a gene therapy approach. Am J Pathol. 2000;156:1381\u20131393.","journal-title":"Am J Pathol"},{"key":"BF7700617_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/jir.1990.10.141","volume":"10","author":"MG Rosenblum","year":"1990","unstructured":"Rosenblum MG, Yung WK, Kelleher PJ, et al. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2\u2032,5\u2032-oligoadenylate synthetase and protein kinase activity. J Interferon Res. 1990;10:141\u2013151.","journal-title":"J Interferon Res"},{"key":"BF7700617_CR48","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/84.15.1185","volume":"84","author":"TG Johns","year":"1992","unstructured":"Johns TG, Mackay IR, Callister KA, et al. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J Natl Cancer Inst. 1992;84:1185\u20131190.","journal-title":"J Natl Cancer Inst"},{"key":"BF7700617_CR49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/mthe.2002.0803","volume":"6","author":"N Kobayashi","year":"2002","unstructured":"Kobayashi N, Kuramoto T, Chen S, et al. Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models. Mol Ther. 2002;6:737\u2013744.","journal-title":"Mol Ther"},{"key":"BF7700617_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4049\/jimmunol.165.1.91","volume":"165","author":"B Lowin-Kropf","year":"2000","unstructured":"Lowin-Kropf B, Held W . Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development. J Immunol. 2000;165:91\u201395.","journal-title":"J Immunol"},{"key":"BF7700617_CR51","first-page":"1185","volume":"51","author":"N Esumi","year":"1991","unstructured":"Esumi N, Hunt B, Itaya T, et al. Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression. Cancer Res. 1991;51:1185\u20131189.","journal-title":"Cancer Res"},{"key":"BF7700617_CR52","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1006\/mthe.2002.0813","volume":"6","author":"H Lu","year":"2002","unstructured":"Lu H, Zhang Y, Roberts DD, et al. Enhanced gene expression in breast cancer cells in vitro and tumors in vivo. Mol Ther. 2002;6:783\u2013792.","journal-title":"Mol Ther"},{"key":"BF7700617_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1525-0016(02)00060-6","volume":"7","author":"MG Kramer","year":"2003","unstructured":"Kramer MG, Barajas M, Razquin N, et al. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol Ther. 2003;7:375\u2013385.","journal-title":"Mol Ther"},{"key":"BF7700617_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0378-1119(01)00550-9","volume":"272","author":"ZL Xu","year":"2001","unstructured":"Xu ZL, Mizuguchi H, Ishii-Watabe A, et al. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene. 2001;272:149\u2013156.","journal-title":"Gene"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700617","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T16:06:35Z","timestamp":1704902795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,28]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9,1]]}},"alternative-id":["BF7700617"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700617","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,28]]},"assertion":[{"value":"16 December 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2003","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}